세계 신경혈관 기기 시장 규모는 예측 기간인 2024-2031년 7.80%의 CAGR로 2023년 33억 5,000만 달러에서 2031년 61억 1,000만 달러로 확대될 것으로 예상됩니다. 신경혈관 기기 시장은 의료기기 산업의 중요한 부분이며 의료기기 산업에서 가장 빠른 성장률을 보이고 있습니다. 신경 질환의 유병률 증가, 최소침습 수술의 채택률 증가, 기술 발전 등의 요인이 시장을 주도하고 있습니다.
뇌동맥정맥기형(AVM)과 뇌동맥류는 신경혈관 기기로 치료하는 뇌혈관 질환의 두 가지 예입니다. 뇌색전술과 동맥류 코일링은 신경혈관 기기의 두 가지 중요한 범주입니다. 2023년 뇌동맥류 치료에 가장 많이 사용되는 뇌동맥류 코일링은 뇌동맥류에 코일 형태로 삽입되어 혈류를 차단하여 혈관을 채우고 혈류를 차단하는 데 사용됩니다. 뇌혈관 성형술 및 스텐트 삽입 시스템은 뇌의 막히거나 제한된 동맥 막힘을 제거하는 데 사용되며 신경혈관 기기의 중요한 부분입니다. 이러한 장치에는 동맥을 열어두기 위해 삽입하는 스텐트와 동맥을 확장하기 위해 팽창시키는 풍선 카테터가 있습니다. 급성 허혈성 뇌졸중에서는 신경 혈전제거 기기를 사용하여 뇌의 막힌 동맥에서 혈전을 제거합니다. 스텐트 리트리버와 흡입 카테터가 그 두 가지 예입니다. 경요골동맥 접근 장치는 사타구니의 대퇴동맥 대신 손목의 요골동맥을 통해 뇌동맥에 접근하는 방법입니다. 이 방법은 환자의 회복 기간을 단축하고 문제를 최소화합니다.
신경혈관질환의 유병률 증가는 신경혈관 의료기기의 수요를 촉진하는 주요 요인으로, CDC 데이터에 따르면 55세 이후 10년마다 뇌졸중 발병 확률이 두 배로 증가한다고 합니다. 고령화, 흡연, 비만, 고혈압 등의 요인으로 인해 전 세계적으로 신경혈관 질환의 발생률은 증가하는 추세입니다. 이러한 신경질환의 진단, 모니터링, 치료를 개선하기 위해 신경혈관 질환을 표적으로 하는 환자 기반이 커지고 빠르게 확대됨에 따라 신경혈관 질환을 대상으로 하는 신경혈관 기기 및 중재적 치료법의 채택이 크게 도움이 되고 있습니다. 세계 뇌졸중 팩트시트 자료에 따르면, 약 1억 100만 명이 뇌졸중을 경험했으며, 15세에서 49세 사이는 뇌졸중 경험자 중 생존자의 22%를 차지합니다.
이 보고서는 세계 신경혈관 기기 시장을 조사하여 시장 개요와 함께 제품별, 용도별, 사이즈별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등의 정보를 제공합니다.
Global neurovascular devices market is projected to witness a CAGR of 7.80% during the forecast period 2024-2031, growing from USD 3.35 billion in 2023 to USD 6.11 billion in 2031. The neurovascular devices market is an important part of the medical device industry, accounting for one of the fastest growth rates in the medical device industry. Factors are driving the market such as increasing prevalence of neurological disorders, rising adoption of minimally invasive surgeries, and technological advancements.
Arteriovenous malformations (AVMs) and cerebral aneurysms are two instances of blood vessel abnormalities in the brain that are treated with neurovascular devices. Cerebral embolization and aneurysm coiling devices are two important categories of neurovascular devices. By filling the pocket and obstructing blood flow, these tiny wires are coiled and placed into the aneurysm. In 2023, embolization coils were used the most for treating brain aneurysms. Cerebral angioplasty and stenting systems, which are used to unblock blocked or restricted arteries in the brain are an important part of neurovascular devices. These devices include stents, which are placed to keep the artery open, and balloon catheters, which are inflated to enlarge the artery. During an acute ischemic stroke, blood clots are removed from blocked arteries in the brain using neurothrombectomy devices. Stent retrievers and aspiration catheters are two instances of these devices. Instead of using the femoral artery in the groin, transradial access devices use the radial artery in the wrist to access the brain's arteries. This method reduces the patient's recovery period and minimizes problems.
In June 2024, Medtronic announced the launch of Artisse intrasaccular device for treating intercranial aneurysms. The launch took place at the same time when preliminary data about the device's performance, safety, and efficacy were made public for the first time at LINNC Paris 2024. Artisse was developed to meet the demands of patients with complicated wide-neck bifurcation aneurysms that were previously treated with intrasaccular basket devices, coil adjunctive neck-bridging devices, and stent-assisted coiling.
Increasing Prevalence of Neurovascular Diseases
The growing prevalence of neurovascular diseases is a key driver fueling the demand for neurovascular medical devices. According to CDC data, the chance of a stroke doubles every ten years after turning 55 years old. The global incidence of neurovascular illness is on the rise due to factors such as the aging population, smoking, obesity, and high blood pressure. To improve diagnosis, monitoring, and treatment of these neurological diseases, the adoption of neurovascular devices and interventional therapeutic procedures is being greatly aided by the sizeable and quickly expanding patient base for targeting neurovascular diseases. According to data from the global stroke fact sheet, approximately 101 million individuals have experienced stroke. 15 to 49-year-olds make up 22% of those who have had a stroke and are still alive.
Technological Advancements to Evolve Neurovascular Devices Market
Innovations in the medical device industry are associated with the development of novel methods, procedures, or technology for the diagnosis, treatment, and management of illness in response to the need for improved patient outcomes and lower healthcare expenses. Medical device companies are continuing to innovate in the neurovascular device industry, concentrating their research and development efforts on advanced technologies that have the potential to enhance outcomes and support the growth of the ischemic and hemorrhagic stroke devices. SmartTRAK identified emerging technologies that could potentially disrupt the neurovascular devices market over the next two to five years in two recent neurointerventional meetings, the 14th European Society for Minimally Invasive Neurological Therapy (ESMINT) Congress 2022 and the 19th Annual Meeting of the Society for NeuroInterventional Surgery (SNIS). It includes new methods of aspiration for the treatment of acute ischemic stroke (AIS), novel intrasaccular flow interruption devices, and supporting technology for neurointerventional treatments.
Cerebral Embolization and Aneurysm Coiling Devices Dominate the Global Neurovascular Devices Market
Cerebral embolization and aneurysm coiling devices dominate the global neurovascular devices market. Brain aneurysms that were previously thought to be incurable can be treated using minimally invasive coil embolization. Compared to open surgery, this approach for the treatment of aneurysms is less invasive and needs a considerably shorter recovery period. Better outcomes can be achieved from coil embolization of small aneurysms with narrow necks than from embolization of big or enormous aneurysms with broad necks. Over 80% of aneurysms treated with coil embolization have proven permanent success in the long term. In August 2023, Microport Neurotech received marketing approval for numen coil embolization system. Numen is categorized as a Category IV high-risk medical device, implying that registering it requires a high level of expertise. The Japanese authorities have approved this neurointerventional device, highlighting its innovative clinical design and excellent performance.
Asia-Pacific is Expected to Grow at the Fastest Rate in the Forecast Period
Asia-Pacific is anticipated to witness a significant growth in the demand for neurovascular devices in the forecast period. The primary drivers for the growth of neurovascular devices in Asia-Pacific are the rising prevalence of neurovascular diseases, growth in adoption of minimally invasive surgeries and geriatric population. Neurovascular diseases that may impact the blood artery network around the brain, results in ailments such as aneurysms and strokes that are treated with neurovascular devices. Increasing awareness of neurovascular procedures and a sizable patient base due to neurovascular illnesses are crucial reasons driving the market expansion in Asia-Pacific. In India, stroke is the second most prevalent cause of death. India encounters about 1,85,000 strokes annually, with one stroke occurring roughly every forty seconds and related mortality occurring every four minutes.
Future Market Scenario (2024-2031F)
The future of neurovascular devices looks promising, driven by advancements in technology and the growing prevalence of neurovascular conditions. Cerebral embolization and aneurysm coiling devices are expected to remain a key focus area, as these thin wire coils that fill and block blood flow to aneurysms continue to be the most preferred treatment methods. Cerebral angioplasty and stenting systems are poised for growth, as they are used to open narrowed or blocked arteries in the brain. Innovations in these devices, such as the development of flow diversion stents, are allowing for more precise and controlled placement during procedures.
Key Players Landscape and Outlook
Several medical device companies are flourishing in the neurovascular devices market by planning and adopting new strategies. They are complying with new strategic initiatives for neurovascular devices to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve higher market share.
EndoStream Medical announced in February 2023, that the first patient was enrolled in the US clinical study for its Nautilus intrasaccular system. The goal of the TORNADO-US clinical research project was to evaluate the Nautilus Intrasaccular System, an innovative device for treating brain aneurysms. The patient was treated in New York at The Mount Sinai Hospital. In addition, Kaneka i-ED coils were utilized in conjunction with the Nautilus Intrasaccular System to treat the patient.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.